Hepatitis C Virus Infection
Semantic Scholar uses AI to extract papers important to this topic.
In efforts to inform public health decision makers, the Global Burden of Diseases, Injuries, and Risk Factors 2010 (GBD2010… Expand BACKGROUND
In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with… Expand Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, with estimates of 4 million HCV… Expand Context The Third National Health and Nutrition Examination Survey (NHANES III), conducted between 1988 and 1994, indicated that… Expand Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality… Expand More than 500 million people worldwide are persistently infected with the hepatitis B virus (HBV) and/or hepatitis C virus (HCV… Expand BACKGROUND
Treatment with peginterferon alfa-2a alone produces significantly higher sustained virologic responses than treatment… Expand Hepatitis C virus (HCV) infects an estimated 170 million persons worldwide and thus represents a viral pandemic, one that is five… Expand BACKGROUND
Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic… Expand Chronic hepatitis C virus (HCV) infection occurs in about 3 percent of the world's population and is a major cause of liver… Expand